It also includes data from a long-term, open-label study that focused on the safety and tolerability of the drug over 26 weeks. Vraylar is now one of AbbVie's fastest-growing products with sales ...

Two medications manufactured by AbbVie, Vraylar and Linzess, are among 15 new drugs selected for the federal government’s new price negotiation program. Vraylar, which North Chicago-based AbbVie ...

The treatment effect was mixed however, as has been seen in other trials of the drug in this setting. There was a significant effect at the lower 1.5mg/day dose of Vraylar, with 44% of patients ...

We also see that global shortages are also more frequent," Orban said. Richter's Cariprazine, an antipsychotic developed in the early 2000s, is approved by the U.S. Food and Drug Administration and ...